AbbVie's revenue misses as Hepatitis C, cancer drugs drag

Filed under: News |

(Reuters) – AbbVie Inc’s quarterly adjusted revenue missed analysts’ estimate as sales of its hepatitis C treatment and cancer therapy came in below Street expectations, overshadowing strong U.S. sales of its flagship Humira drug.

Source:: AbbVie's revenue misses as Hepatitis C, cancer drugs drag

      

List your business in the premium web directory for free This website is listed under Human Resources Directory